Skip to main content

Table 1 The clinical profiles and tumor characteristics of 7 HCC patients with PVT and another 7 patients without PVT

From: Down-regulation of metabolic proteins in hepatocellular carcinoma with portal vein thrombosis

 

PVT (n = 7)

No PTV (n = 7)

p

Gender (M/F)

7/0

5/2

0.462

Age [median(range)]

47 (39–71)

69 (53–79)

0.016

Operation

   

 Lobectomy

4

0

0.070

 Segmentectomy

3

7

 

Tumor

   

 Size [median(range)] (cm)

8 (5–13)

4 (3.5–4.8)

<0.001

 Vascular invasion (+/−)

7/0

0/7

<0.001

 Encapsulation (+/−)

3/4

7/0

0.070

 Daughter nodule (+/−)

4/3

1/6

0.266

 Diffentiation grade

   

  1

0

0

0.229

  2

2

5

 

  3

4

2

 

  4

1

0

 

Hepatitis

   

 B (−)C (−)

2

1

0.801

 B (+)C (−)

4

5

 

 B (−)C (+)

1

1

 

 B (+)C (+)

0

0

 

Cirrhosis (+/−)

6/1

5/2

1.000

AFP [median(range)] (ng/mL)

11.4 (2–1937)

11.0 (4.6–9198)

1.000

Survival [median(range)] (months)

4 (2.5–47)

53 (33–85)

0.002

  1. PVT portal vein thrombosis, AFP α-fetal protein